Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
ACHIEVE LIFE SCIENCES, INC. (ACHV)
Standardized SEC financial data for ACHIEVE LIFE SCIENCES, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000949858 · NASDAQ · In Vitro & In Vivo Diagnostic Substances.
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
R&D expense
$6.9M
$24.0M
$30.1M
$15.8M
$22.8M
—
SG&A expense
$7.9M
$9.1M
$10.7M
$11.4M
$16.3M
—
Interest expense
—
—
$1.8M
$2.9M
—
—
Pretax income
-$14.7M
-$33.2M
-$42.4M
-$29.8M
-$39.8M
-$54.6M
Net income
-$14.7M
-$33.2M
-$42.4M
-$29.8M
-$39.8M
-$54.6M
EPS (diluted)
$-5.42
$-4.08
$-4.00
$-1.50
$-1.24
$-1.25
Standardized from ACHIEVE LIFE SCIENCES, INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.